ONCOPEPTIDES AB O.N. revenue breakdown overview

ONCOPEPTIDES AB O.N. revenue for the last year amounted to 3.27 M EUR, the most of which — 3.15 M EUR — came from its highest performing source at the moment, Pharmaceutical Drugs, the year earlier bringing 745.53 k EUR. The greatest contribution to the revenue figure was made by United States — last year it brought ONCOPEPTIDES AB O.N. 2.18 M EUR, and the year before that — 695.56 k EUR.